News Image

For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals.

By Mill Chart

Last update: Jul 3, 2024

Our stock screening tool has pinpointed INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) as an undervalued stock. NASDAQ:IART maintains a solid financial footing. Furthermore, it remains attractively priced. Let's delve into the specifics below.


Undervalued stocks image

A Closer Look at Valuation for NASDAQ:IART

An integral part of ChartMill's stock analysis is the Valuation Rating, which spans from 0 to 10. This rating evaluates diverse valuation factors, including price to earnings and cash flows, while considering the stock's profitability and growth. NASDAQ:IART has received a 7 out of 10:

  • IART is valuated reasonably with a Price/Earnings ratio of 10.03.
  • 97.33% of the companies in the same industry are more expensive than IART, based on the Price/Earnings ratio.
  • IART's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.32.
  • A Price/Forward Earnings ratio of 8.62 indicates a reasonable valuation of IART.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IART indicates a rather cheap valuation: IART is cheaper than 98.40% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 20.13, IART is valued rather cheaply.
  • 93.58% of the companies in the same industry are more expensive than IART, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, IART is valued cheaply inside the industry as 82.35% of the companies are valued more expensively.
  • The decent profitability rating of IART may justify a higher PE ratio.

Assessing Profitability for NASDAQ:IART

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:IART scores a 7 out of 10:

  • The Return On Assets of IART (0.99%) is better than 73.26% of its industry peers.
  • The Return On Equity of IART (2.52%) is better than 74.33% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.15%, IART is in the better half of the industry, outperforming 77.01% of the companies in the same industry.
  • IART has a Profit Margin of 2.63%. This is in the better half of the industry: IART outperforms 72.73% of its industry peers.
  • The Operating Margin of IART (15.14%) is better than 85.03% of its industry peers.
  • IART's Operating Margin has improved in the last couple of years.

Evaluating Health: NASDAQ:IART

ChartMill utilizes a Health Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of liquidity and solvency ratios, both in absolute terms and in comparison to industry peers. NASDAQ:IART has earned a 5 out of 10:

  • IART has a better Debt to FCF ratio (30.49) than 67.91% of its industry peers.
  • A Current Ratio of 4.68 indicates that IART has no problem at all paying its short term obligations.
  • IART has a Current ratio of 4.68. This is in the better half of the industry: IART outperforms 66.84% of its industry peers.
  • IART has a Quick Ratio of 3.35. This indicates that IART is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.35, IART is in the better half of the industry, outperforming 62.57% of the companies in the same industry.

Exploring NASDAQ:IART's Growth

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:IART has received a 4 out of 10:

  • IART is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.76% yearly.
  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Every day, new Decent Value stocks can be found on ChartMill in our Decent Value screener.

For an up to date full fundamental analysis you can check the fundamental report of IART

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

INTEGRA LIFESCIENCES HOLDING

NASDAQ:IART (10/14/2024, 8:00:02 PM)

After market: 19.22 0 (0%)

19.22

-0.01 (-0.05%)

Follow us for more